BCM
AMGN icon

Berbice Capital Management’s Amgen AMGN Stock Holding History

Berbice Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$28.2K – 147
2025
Q3 		$28.2K Hold
100
– – 0.02% 117
2025
Q2 		$27.9K Hold
100
– – 0.02% 109
2025
Q1 		$31.2K Sell
100
-660
-87% -$195K 0.03% 100
2024
Q4 		$198K Buy
+760
New +$225K 0.16% 47

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Berbice Capital Management's AMGN Position: Q4 2025 in Review

Berbice Capital Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 100 shares — an estimated $28.2K sold.

Berbice Capital Management first reported a position in AMGN in Q4 2024 and held it in 4 quarters. The position peaked at $198K in Q4 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Berbice Capital Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Berbice Capital Management sold 100 Amgen shares in Q4 2025, an estimated $28.2K.
  • Berbice Capital Management first reported a position in Amgen in Q4 2024 and held it in 4 quarters.
  • Berbice Capital Management's Amgen position peaked at $198K in Q4 2024.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Berbice Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.